Current Progress

Submission received

NMG meeting

AWMSG meeting

Ministerial Ratification

AWMSG advice

Vildagliptin (Galvus®) is recommended as an option for use within NHS Wales for the treatment of type 2 diabetes mellitus as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance.